文献速递胸部病理细胞病理与分子病理

非小细胞肺癌及其类似病变的细胞学与小活检实用诊断方法:与WHO报告系统对齐

Non-small cell lung carcinoma and its mimics on cytology and small biopsy samples: a practical approach aligned with the WHO Reporting System.
PubMed 文献 · Cancer Cytopathol · 2026-01-01

本文综述了细胞学标本和小活检中非小细胞肺癌及其类似病变的诊断挑战,涵盖关键细胞形态特征、实用免疫细胞化学策略及常见诊断陷阱。重点强调在EBUS-TBNA和FNA样本中合理使用有限免疫组化套餐以优化肿瘤分型并保留材料用于分子检测,通过形态学与辅助检测结合实现精准分型和鉴别类似病变。

要点

  • 细胞学和小活检因细胞量有限、分析前变量及形态重叠,肺癌分类仍具挑战。
  • 有限免疫组化套餐可优化分型同时保留材料用于分子检测。
  • 需警惕挤压伪影、坏死、反应性类似病变及罕见肿瘤误分类风险。

核心结论

  • 整合形态学评估与辅助检测,细胞病理医生可实现准确肿瘤分型、鉴别类似病变并提供指导临床管理和靶向治疗选择的精准诊断。

研究设计与样本

  • 本文为综述,总结EBUS-TBNA和FNA样本中非小细胞肺癌、小细胞肺癌、神经内分泌肿瘤、继发性肺肿瘤及少见胸部病变的关键细胞形态特征和实用免疫细胞化学策略。

主要发现

  • 细胞学标本和小活检中肺癌准确分类受限于细胞量有限、分析前变量及实体间显著形态重叠。
  • 诊断挑战包括挤压伪影、坏死、反应性类似病变、重叠形态模式及罕见肿瘤误分类风险。

临床怎么用

  • 在EBUS-TBNA和FNA样本中合理使用有限免疫组化套餐,优化肿瘤分型同时保留材料用于分子检测。
  • 结合形态学与辅助检测鉴别类似病变,提供精准诊断以指导临床管理和靶向治疗选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Accurate classification of lung tumors in cytology specimens and small biopsies remains a diagnostic challenge because of limited cellularity, preanalytical variables, and significant morphologic overlap among entities. This review summarizes key cytomorphologic characteristics and practical immunocytochemical strategies, and common diagnostic pitfalls encountered in the evaluation of non-small cell lung carcinoma, small cell lung carcinoma, neuroendocrine tumors, secondary pulmonary neoplasms, and uncommon thoracic entities in endobronchial ultrasound-guided transbronchial needle aspiration and fine-needle aspiration samples. Particular emphasis is placed on the appropriate use of limited immunohistochemical panels to optimize tumor subtyping while preserving material for molecular testing. Diagnostic challenges such as crush artifact, necrosis, reactive mimics, overlapping morphologic patterns, and the risk of misclassification of rare tumors are addressed with practical guidance for differential diagnosis. By integrating morphologic assessment with ancillary testing, cytopathologists can achieve accurate tumor subtyping, distinguish mimics, and provide precise diagnoses that guide clinical management and selection of targeted therapies.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Silva RSD, Schmitt F. Non-small cell lung carcinoma and its mimics on cytology and small biopsy samples: a practical approach aligned with the WHO Reporting System. Cancer Cytopathol. 2026. PMID: 42902931. doi:10.1002/cncy.70150

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。